These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 3556774)
1. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Glück R; Hoskins JM; Wegmann A; Just M; Germanier R Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774 [TBL] [Abstract][Full Text] [Related]
2. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines. Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778 [TBL] [Abstract][Full Text] [Related]
3. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine. Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780 [TBL] [Abstract][Full Text] [Related]
4. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine. André FE; Peetermans J Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. Just M; Berger R; Glück R; Wegmann A Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399 [TBL] [Abstract][Full Text] [Related]
6. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. Ong G; Goh KT; Ma S; Chew SK J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282 [TBL] [Abstract][Full Text] [Related]
8. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [TBL] [Abstract][Full Text] [Related]
9. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines. Weibel RE; Buynak EB; McLean AA; Hilleman MR Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873 [TBL] [Abstract][Full Text] [Related]
10. Development and biological properties of a new live attenuated mumps vaccine. Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119 [TBL] [Abstract][Full Text] [Related]
11. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
12. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869 [TBL] [Abstract][Full Text] [Related]
13. Development of a new live attenuated mumps virus vaccine in human diploid cells. Sassani A; Mirchamsy H; Shafyi A; Ahourai P; Razavi J; Gholami MR; Mohammadi A; Ezzi A; Rahmani M; Fateh G Biologicals; 1991 Jul; 19(3):203-11. PubMed ID: 1954002 [TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
15. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077 [TBL] [Abstract][Full Text] [Related]
16. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)]. Chamot E; Toscani L; Egger P; Germann D; Bourquin C Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852 [TBL] [Abstract][Full Text] [Related]
17. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella]. Just M; Berger R; Glück R; Wegmann A Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704 [TBL] [Abstract][Full Text] [Related]
18. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
19. Aseptic meningitis after vaccination against measles and mumps. Cizman M; Mozetic M; Radescek-Rakar R; Pleterski-Rigler D; Susec-Michieli M Pediatr Infect Dis J; 1989 May; 8(5):302-8. PubMed ID: 2726323 [TBL] [Abstract][Full Text] [Related]
20. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren. Christenson B; Heller L; Böttiger M J Biol Stand; 1983 Oct; 11(4):323-31. PubMed ID: 6643511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]